|
English
|
正體中文
|
简体中文
|
2815039
|
|
???header.visitor??? :
27333060
???header.onlineuser??? :
691
???header.sponsordeclaration???
|
|
|
|
???tair.name??? >
???browser.page.title.author???
|
"wang peng j"???jsp.browse.items-by-author.description???
Showing items 1-5 of 5 (1 Page(s) Totally)
1
View [10|25|50] records per page
| 臺大學術典藏 |
2021-07-03T03:34:41Z |
A randomised phase II study of pegylated arginine deiminase (ADI-PEG 20) in Asian advanced hepatocellular carcinoma patients
|
Yang T.-S.; Lu S.-N.; Chao Y.; Sheen I.-S.; Lin C.-C.; Wang T.-E.; Chen S.-C.; Wang J.-H.; Liao L.-Y.; Thomson J.A.; Wang-Peng J.; PEI-JER CHEN; Chen L.-T. |
| 國家衛生研究院 |
2015-03-12 |
Elimination of cancer stem-like cells and potentiation of temozolomide sensitivity by honokiol in glioblastoma multiforme cells
|
Lai, IC;Shih, PH;Yao, CJ;Yeh, CT;Wang-Peng, J;Lui, TN;Chuang, SE;Hu, TS;Lai, TY;Lai, GM |
| 高雄醫學大學 |
2011 |
A randomised phase II study of pegylated arginine deiminase (ADI-PEG 20) in Asian advanced hepatocellular carcinoma patients.
|
盧勝男;趙毅;王蒼恩;陳信成;彭康嘉康;陳培哲;陳立宗 ; Yang TS;Lu SN;Chao Y;Sheen IS;Lin CC;Wang TE;Chen SC;Wang JH;Liao LY;Thomson JA;Wang-Peng J;Chen PJ;Chen LT. |
| 國家衛生研究院 |
2010-09 |
A randomised phase II study of pegylated arginine deiminase (ADI-PEG 20) in Asian advanced hepatocellular carcinoma patients
|
Yang, TS;Lu, SN;Chao, Y;Sheen, IS;Lin, CC;Wang, TE;Chen, SC;Wang, JH;Liao, LY;Thomson, JA;Wang-Peng, J;Chen, PJ;Chen, LT |
| 臺北醫學大學 |
2001 |
Morbidity after D1 and D3 surgery for gastric cancer.
|
謝茂志; Wu CW; Hsiung C; Lo SS; Hsieh MC; Shen KH; Shia LT; Lui WY; P’eng FK; Wang-Peng J |
Showing items 1-5 of 5 (1 Page(s) Totally)
1
View [10|25|50] records per page
|
